Literature DB >> 7882288

Risk factors for infection of adult patients with cancer who have tunnelled central venous catheters.

P B Howell1, P E Walters, G R Donowitz, B M Farr.   

Abstract

BACKGROUND: Long-dwelling tunnelled central venous catheters provide reliable access for infusion therapy of patients with cancer, but can result in serious bloodstream infections. The incidence of such infections has been documented, but few studies have assessed potential risk factors, and to the authors' knowledge, none have measured the effect of neutropenia upon the incidence of these infections.
METHODS: A cohort of 71 adult patients with cancer with long-dwelling tunnelled central venous catheters was followed for a total of 12,410 catheter days until catheter removal, death, or end of study for the occurrence of catheter-related infection or sepsis of unknown origin. Fifteen factors were assessed for association with these infections.
RESULTS: Thirteen patients (18%) experienced a catheter-related infection (1.0/1000 catheter days), and 23 (32%) experienced sepsis of unknown origin. Neutropenia was associated significantly with risk for catheter-related infection (relative risk [RR] = 15.1, 95% confidence interval [CI] 2.7-86.9) and sepsis of unknown origin (RR = 10.3, 95% CI 4.0-26.8). Inpatient status, acute leukemia, and cytosine arabinoside therapy also were associated with sepsis of unknown origin, but not when adjusted for neutropenia.
CONCLUSION: Of the 15 potential risk factors studied, neutropenia was the only independent risk factor for infection related to long-dwelling tunnelled central venous catheters and for sepsis of unknown origin.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7882288     DOI: 10.1002/1097-0142(19950315)75:6<1367::aid-cncr2820750620>3.0.co;2-z

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  14 in total

1.  Summary of recommendations: Guidelines for the Prevention of Intravascular Catheter-related Infections.

Authors:  Naomi P O'Grady; Mary Alexander; Lillian A Burns; E Patchen Dellinger; Jeffrey Garland; Stephen O Heard; Pamela A Lipsett; Henry Masur; Leonard A Mermel; Michele L Pearson; Issam I Raad; Adrienne G Randolph; Mark E Rupp; Sanjay Saint
Journal:  Clin Infect Dis       Date:  2011-05       Impact factor: 9.079

2.  Guidelines for the prevention of intravascular catheter-related infections.

Authors:  Naomi P O'Grady; Mary Alexander; Lillian A Burns; E Patchen Dellinger; Jeffrey Garland; Stephen O Heard; Pamela A Lipsett; Henry Masur; Leonard A Mermel; Michele L Pearson; Issam I Raad; Adrienne G Randolph; Mark E Rupp; Sanjay Saint
Journal:  Clin Infect Dis       Date:  2011-04-01       Impact factor: 9.079

3.  Chlorhexidine and silver-sulfadiazine coated central venous catheters in haematological patients--a double-blind, randomised, prospective, controlled trial.

Authors:  Torben Ostendorf; Andrea Meinhold; Christoph Harter; Hans Salwender; Gerlinde Egerer; Heinrich K Geiss; Antony D Ho; Hartmut Goldschmidt
Journal:  Support Care Cancer       Date:  2005-04-16       Impact factor: 3.603

4.  Randomized, double-blind trial of an antibiotic-lock technique for prevention of gram-positive central venous catheter-related infection in neutropenic patients with cancer.

Authors:  J Carratalà; J Niubó; A Fernández-Sevilla; E Juvé; X Castellsagué; J Berlanga; J Liñares; F Gudiol
Journal:  Antimicrob Agents Chemother       Date:  1999-09       Impact factor: 5.191

5.  Reducing catheter-associated infections with silver-impregnated catheters in long-term therapy of children.

Authors:  R T Carbon; S Lugauer; U Geitner; A Regenfus; M Böswald; J Greil; T Bechert; S I Simon; H P Hümmer; J P Guggenbichler
Journal:  Infection       Date:  1999       Impact factor: 3.553

6.  Guidelines for the prevention of intravascular catheter-related infections: recommendations relevant to interventional radiology for venous catheter placement and maintenance.

Authors:  Donald L Miller; Naomi P O'Grady
Journal:  J Vasc Interv Radiol       Date:  2012-08       Impact factor: 3.464

7.  Safety and effectiveness of central venous catheterization in patients with cancer: prospective observational study.

Authors:  Hyun Jung Kim; Jina Yun; Han Jo Kim; Kyoung Ha Kim; Se Hyung Kim; Sang-Cheol Lee; Sang Byung Bae; Chan Kyu Kim; Nam Su Lee; Kyu Taek Lee; Seong Kyu Park; Jong-Ho Won; Hee Sook Park; Dae Sik Hong
Journal:  J Korean Med Sci       Date:  2010-11-24       Impact factor: 2.153

8.  Removal of totally implanted venous access ports for suspected infection in the intensive care unit: a multicenter observational study.

Authors:  Marie Lecronier; Sandrine Valade; Naike Bigé; Nicolas de Prost; Damien Roux; David Lebeaux; Eric Maury; Elie Azoulay; Alexandre Demoule; Martin Dres
Journal:  Ann Intensive Care       Date:  2018-03-27       Impact factor: 6.925

9.  Clinical characteristics of Stenotrophomonas maltophilia infection in hematopoietic stem cell transplantation recipients: a single center experience.

Authors:  M Yeshurun; A Gafter-Gvili; M Thaler; N Keller; A Nagler; A Shimoni
Journal:  Infection       Date:  2010-04-28       Impact factor: 3.553

10.  A case-control study to identify risk factors for totally implantable central venous port-related bloodstream infection.

Authors:  Guk Jin Lee; Sook Hee Hong; Sang Young Roh; Sa Rah Park; Myung Ah Lee; Hoo Geun Chun; Young Seon Hong; Jin Hyoung Kang; Sang Il Kim; Youn Jeong Kim; Ho Jong Chun; Jung Suk Oh
Journal:  Cancer Res Treat       Date:  2014-07-15       Impact factor: 4.679

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.